FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Promethazine Suppository
Status: Discontinuation
»Therapeutic Categories: Anesthesia; Gastroenterology; Pediatric; Pulmonary/Allergy

Expand all

Mylan Pharmaceuticals Inc. (New 12/13/2018)

Company Contact Information:
800-796-9526

Presentation Posting Date Related Information
Promethazine Suppositories 12.5mg Bx12 (NDC 40085-218-12) 12/13/2018 A business decision was made to discontinue manufacture of the drug product
Promethazine Suppositories 25mg Bx12 (NDC 40085-219-12) 12/13/2018 A business decision was made to discontinue manufacture of the drug product
Promethazine Suppositories 50mg Bx12 12/13/2018 A business decision was made to discontinue manufacture of the drug product

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English